Conclusion: The perioperative management of patients taking incretinbased therapies (GLP1 and GIP receptor agonists) and SGLT2 inhibitors is evolving as these drugs gain widespread use for diabetes, obesity, and cardiorenal protection
When we are young, this process is robust, but aging, chronic disease, poor circulation, and repetitive injuries can create an environment that impairs the bodys ability to heal
More than 3,000 product liability lawsuits are pending, largely focused on gastroparesis and vision injuries such as non-arteritic anterior ischemic optic neuropathy (NAION), now centralized in two MDLs in the Eastern District of Pennsylvania before Judge Karen Marston
GLP-1 Up supports your bodys natural GLP-1 production the hormone that helps regulate appetite, blood sugar, and energy
Itll be a little morbid, so I can get morning sunlight